Track record · closed signal

The Interpublic Group of Companies, Inc. (IPG) — closed signal from October 7, 2025

Partial Published before the outcome was known, scored automatically when the window closed on January 5, 2026.

Predicted vs. what happened

IPG price · publication thesis → realized outcomesplit-adjusted
$27.25 Published $32.16 Target $24.57 Window close $28.24 Peak
$26.50 – $27.10Entry zone — fair-value band
$27.25Published — price the day we called it
$32.16Target — the price the thesis aimed for
$28.24Peak — highest point inside the window, not a realized return
$24.57Window close — end-of-window price, context only

What happened

Partial

Reached 20% of the predicted growth at its peak, without hitting the target.

Peak price
$28.24
peak on October 22, 2025 — not a realized return
Peak gain
+3.6%
peak, from the publication price
Window close
$24.57
end-of-window price, context only
Days to target
Window
October 7, 2025 – January 5, 2026

The thesis — published October 7, 2025

Predicted growth
+18%
over the measurement window
Target price
$32.16
the price the thesis aimed for
Entry zone
$26.50 – $27.10
the fair-value band we waited for
Price at publication
$27.25
published October 7, 2025
Confidence
73%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

IPG seems to be regaining strength with real wins and signs of trust. More buyers than usual are stepping in, and the recent average price is edging up. The company also earned new security-cloud approvals and won Bayer's global account, which can steady future sales. If the overall market stays friendly, these wins could lift the stock over the next 3 months.

Primary drivers

  • Won Bayer's global advertising work, adding a large, steady stream of projects.
  • New security-cloud certifications that reassure big clients and help win deals.
  • Buying interest is returning with heavier activity, a sign confidence is improving.
  • Brands are slowly spending more on ads, creating a friendlier sales environment.

How it played out

IPG: the target was not reached

On October 7, 2025, Lyra published a short-term IPG thesis at $27.25. It expected 18% growth toward $32.16 over the next 3 months. The thesis pointed to Bayer's global advertising work, new security-cloud approvals, returning buying interest with heavier activity, and a friendlier ad-spending backdrop.

Inside the window, IPG rose to $28.24 on October 22, 2025, a 3.6% peak gain. It never reached $32.16. By January 5, 2026, it ended at $24.57. The thesis partly worked early, but the target missed and the closing price was below the publication price.

What happened during the window

On November 26, 2025, Omnicom completed its acquisition of Interpublic. On December 1, 2025, Business Insider reported that Omnicom planned around 4,000 acquisition-related job cuts after the deal closed.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.